ACTINIUM PHARMACEUTICALS INC (ATNM) Stock Balance Sheet
NYSEARCA:ATNM - NYSE Arca - US00507W2061 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 65.33M | 72.90M | 76.68M | 108.91M | 77.83M | |||
| Other Current Assets | 1.13M | 1.60M | 1.59M | 2.03M | 1.92M | |||
| Total Current Assets | 66.46M | 74.51M | 78.26M | 110.94M | 79.75M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.86M | 2.07M | 2.87M | 2.95M | 639.00K | |||
| Other Non-Current Assets | 327.00K | 324.00K | 313.00K | 302.00K | 0.00 | |||
| Total Non-Current Assets | 2.19M | 2.39M | 3.18M | 3.25M | 639.00K | |||
| TOTAL ASSETS | 68.65M | 76.90M | 81.44M | 114.19M | 80.39M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 11.00K | 11.00K | 11.00K | 4.00K | 62.00K | |||
| Accrued Expenses | 579.00K | 569.00K | 530.00K | 494.00K | 245.00K | |||
| Accounts Payable | 6.52M | 7.57M | 7.95M | 10.13M | 5.54M | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 998.00K | |||
| Total Current Liabilities | 7.11M | 8.15M | 8.49M | 10.63M | 6.84M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 7.00K | 9.00K | 19.00K | 0.00 | 3.00K | |||
| Other Non-Current Liabilities | 35.84M | 35.98M | 36.55M | 37.08M | 0.00 | |||
| Total Non-Current Liabilities | 35.84M | 35.99M | 36.57M | 37.08M | 3.00K | |||
| TOTAL LIABILITIES | 42.95M | 44.14M | 45.07M | 47.71M | 6.84M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -391.76M | -375.83M | -337.58M | -288.76M | -255.75M | |||
| Additional Paid In Capital | 417.43M | 408.55M | 373.93M | 355.22M | 329.27M | |||
| Common Shares | 31.00K | 31.00K | 28.00K | 26.00K | 22.00K | |||
| Shares Outstanding | 31.20M | 31.20M | 27.63M | 25.67M | 22.14M | |||
| Tangible Book Value per Share | 0.82 | 1.05 | 1.32 | 2.59 | 3.32 | |||
| Total Shareholders' Equity | 25.69M | 32.76M | 36.38M | 66.48M | 73.55M | |||
| TOTAL LIABILITIES AND EQUITY | 68.65M | 76.90M | 81.44M | 114.19M | 80.39M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | N/A | 0.00 | |||
| Current Ratio | 9.35 | 9.14 | 9.21 | 10.44 | 11.66 | |||
| Return On Assets (ROA) | -66.30% | -49.73% | -59.94% | -28.91% | -30.82% | |||
| Return On Equity (ROE) | -177.13% | -116.74% | -134.19% | -49.66% | -33.69% | |||
All data in USD , ROIC based on taxRate of 0.21